Metraipolis › archive › dc_7eb45505939d
Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42332460
- DOI
- 10.1097/md.0000000000049290
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T01:33:46.295Z
- SHA-256 of the archived text
9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e- Stable URL of this page
https://metraipolis.com/documento/dc_7eb45505939d
How to cite
Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460 — Europe PMC (en), https://europepmc.org/article/MED/42332460 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7eb45505939d (Metraipolis archive dc_7eb45505939d, sha256 9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e)
BibTeX
@misc{dc7eb45505939d,
title = {Efficacy and safety of combination immunotherapy and targeted therapy as second-line and subsequent treatments for advanced biliary tract cancer: A systematic… — Europe PMC PMID:42332460},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42332460},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7eb45505939d; sha256 9f25c3b620af14cdb6617100093a53c68357c7bfa386591acc91ccef7d73e83e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42332460. Agents can read the archived copy with the MCP tool read_document.